<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88136377-F05B-4E13-AC19-462675995B43"><gtr:id>88136377-F05B-4E13-AC19-462675995B43</gtr:id><gtr:name>Latin American Collaborative Study of Congenital Malformations</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/245EB81A-808F-4697-BAED-263C20266B74"><gtr:id>245EB81A-808F-4697-BAED-263C20266B74</gtr:id><gtr:name>University of Ulster</gtr:name><gtr:address><gtr:line1>Cromore Road</gtr:line1><gtr:line4>Coleraine</gtr:line4><gtr:line5>County Londonderry</gtr:line5><gtr:postCode>BT52 1SA</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/245EB81A-808F-4697-BAED-263C20266B74"><gtr:id>245EB81A-808F-4697-BAED-263C20266B74</gtr:id><gtr:name>University of Ulster</gtr:name><gtr:address><gtr:line1>Cromore Road</gtr:line1><gtr:line4>Coleraine</gtr:line4><gtr:line5>County Londonderry</gtr:line5><gtr:postCode>BT52 1SA</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88136377-F05B-4E13-AC19-462675995B43"><gtr:id>88136377-F05B-4E13-AC19-462675995B43</gtr:id><gtr:name>Latin American Collaborative Study of Congenital Malformations</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8BE8FF64-373A-4BE4-B57D-51021083E720"><gtr:id>8BE8FF64-373A-4BE4-B57D-51021083E720</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:surname>Dolk</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15098"><gtr:id>EA797D65-C157-41E9-9E12-06B471A053C9</gtr:id><gtr:title>Zika: Establishment of enhanced birth defect surveillance in South America</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15098</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Although one of the main reasons that WHO has pronounced Zika Virus
(ZIKV) a Public Health Emergency of International Concern is its putative link
with microcephaly, the scientific evidence remains unclear and uncertain. To
increase the knowledge needed to guide public health actions, this project will use an established
network dedicated to the congenital defect research in the last 49 years in South America, the
Latin American Collaborative Study of Congenital Malformations (ECLAMC), currently
operating in 21 hospitals in 7 countries. First we propose an epidemiological analysis of
microcephaly data from ECLAMC in the 10 years pre-Zika, and a comparison to the period of
Zika outbreak for each country. The second deliverable will be a piloted protocol, and first 9
months results, for enhanced surveillance of history of maternal viral infection in ECLAMC
hospitals. Viral infection testing for cases of microcephaly, selected eye defects/other birth
defects, children from mothers possibly exposed to viral infection, and control babies, will be
included, with sampling strategy modified to suit the degree of Zika circulation in the local
population. Genetic testing will be done for all microcephaly cases. The third deliverable will be a
piloted protocol of a follow-up study of babies with microcephaly and/or history of Zika during
pregnancy and a sample of surveillance controls in ECLAMC participating hospitals, up to 5 years
of age, using validated neurodevelopmental questionnaires.</gtr:technicalSummary><gtr:fund><gtr:end>2017-10-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-31</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>15530</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Latin American Collaborative Study of Congenital Malformations</gtr:collaboratingOrganisation><gtr:country>Argentina, Argentine Republic</gtr:country><gtr:description>ECLAMC</gtr:description><gtr:id>A1DEE6A7-4569-43DC-A551-C6671474E256</gtr:id><gtr:impact>Still on-going</gtr:impact><gtr:outcomeId>58c01b5f0fbc27.07095387-1</gtr:outcomeId><gtr:partnerContribution>Their time, expertise and data</gtr:partnerContribution><gtr:piContribution>My time and expertise</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>304658734</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>EU Horizon 2020</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>734584</gtr:fundingRef><gtr:id>CD3F5144-CA44-47A9-B3E1-EA16723BD24F</gtr:id><gtr:outcomeId>58c01c5ea098a6.15796823</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>061C4DE8-CFC5-4FEC-B6EB-DA1CBE54232E</gtr:id><gtr:title>Prevalence and clinical profile of microcephaly in South America pre-Zika, 2005-14: prevalence and case-control study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4b47c2e7f1252713359c384efc14248"><gtr:id>d4b47c2e7f1252713359c384efc14248</gtr:id><gtr:otherNames>Orioli IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5a74be68d79be2.71496560</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15098</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>